
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.870 | 1.870 | 0.000 |
Shares | 98.130 | 98.130 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.311 | 20.409 |
Price to Book | 4.043 | 4.040 |
Price to Sales | 2.065 | 2.449 |
Price to Cash Flow | 14.987 | 16.330 |
Dividend Yield | 2.023 | 1.369 |
5 Years Earnings Growth | 10.095 | 12.019 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.440 | 94.855 |
Consumer Cyclical | 0.560 | 8.507 |
Number of long holdings: 57
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.68 | 754.35 | +3.00% | |
J&J | US4781601046 | 5.38 | 154.36 | +1.73% | |
AbbVie | US00287Y1091 | 5.35 | 179.10 | +2.31% | |
UnitedHealth | US91324P1021 | 4.86 | 587.06 | -2.07% | |
AstraZeneca | GB0009895292 | 3.15 | 10,320.0 | +3.12% | |
Amgen | US0311621009 | 3.13 | 293.92 | +2.78% | |
Merck&Co | US58933Y1055 | 3.12 | 79.17 | -0.01% | |
Novo Nordisk B | DK0062498333 | 3.10 | 435.9 | +3.71% | |
Thermo Fisher Scientific | US8835561023 | 3.08 | 449.33 | +2.55% | |
Novartis | CH0012005267 | 2.91 | 88.74 | +3.08% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -6.78 | - | ||
FIM Emerging markets ESG | 431.72M | 1.97 | 1.37 | 2.64 | ||
S SaastOrahasto Kohtuullinen | 312.2M | -3.08 | 3.81 | 4.32 | ||
S-Saastorahasto Rohkea | 293.57M | -4.00 | 5.50 | 6.20 | ||
FIM USA | 250.97M | -8.73 | 8.93 | 9.62 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review